12:00 AM
Dec 09, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Hemispherx management update

Hemispherx Biopharma Inc. (NYSE-M:HEB), Philadelphia, Pa.
Business: Infectious, Neurology
Transitioning: Thomas Equels to CFO...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >